This is definitely my favorite kind of teaser ad — the mysterious element, the hidden asset, the pioneering scientists, we get it all! Here’s the bit that got me interested: “On December, 1996, researchers stumbled onto something truly remarkable. “A discovery that could be straight out of an X-Files episode… “A tiny, extraterrestrial stone… “Buried […]
Articles
- Most Relevant
- Most Recent
The basic premise of this ad is pretty familiar — you can get good returns without risk. Isn’t that what everyone wants? Presumably the nitty gritty detail is a little different, but, well, who can think about details when they’re under the hypnotic spell of an expert copywriter who’s weaving a tale about secret accounts […]
I thought this was going to be another pitch for what’s lately been teased very aggressively as invisible “770 Account” participating whole life insurance by the Palm Beach Folks… so I almost tossed the email (there are only so many times you can run through that story). But this is a little bit different — […]
Shah Gilani has a new pitch going around for his Capital Wave Forecast, all about how the short-selling and manipulation by the six big bullion-trading banks brought the “flash crash” in gold and drove it lower … but will certainly drive it higher now that the move is done, with his expected price of $2,500 […]
Before you get sucked into reading more of my blather, take a moment and read the Wall Street Journal if you’ve got a copy nearby or an online subscription — not the whole thing, but read Christopher Mims’ column The World Isn’t as Bad as Your Wired Brain Tells You. It’s an unusually brief and […]
Rob Fannon and Dr. George Huang are analysts for a newsletter called The Medical Investor, and their publisher, George Rayburn, has a deal for you … sign up for a subscription, and you’ll get their new report, “The Most Profitable New Medical Device Investment in the World Right Now.” Or of course, since you’re a […]
This article originally appeared on January 28, 2015, when the ad was newly released — the same ad, without any major revisions that we noticed, is being distributed widely again and generating questions, so we make this piece available again. The stock teased is at roughly the same price now as it was on January […]
Ian Cooper is teasing us about an options trade on a little biotech stock again — you might remember that about a year ago he and a few others were throwing out hyperactive teaser ads regarding Arena Pharmaceuticals, the company with a new weight loss drug that was on the verge of releasing results of […]
Every biotech-related teaser ad promises that you can make life-changing profits while also curing the world of a dread disease, of course — that’s why we love ’em. But this one’s a little bit different — they are teasing a biotech company that is trying to develop new drugs, but according to the pitch this […]
Patrick Cox is not a shy guy. I don’t think I’ve ever read one of his biotech teaser ads that didn’t leave me convinced (at least for a moment) that the world was about to be changed because of the newest potion or pill that his favorite little companies were developing. And this latest one […]
Now this is how a teaser ad should look! Any editor can promise huge gains — and heck, maybe even occasionally deliver on those dramatic gains if they get lucky or smart for a moment in time … but how many investment newsletters can tease that you’ll “live 20 years longer?” Here’s how Patrick Cox […]
Responses to Comments & Short Takes[ed. note: We feature the writings of Doc Gumshoe, our favorite medical scribe, every few weeks here at Stock Gumshoe. He is not a doctor, but we value his insight, research, contrariness and skepticism … and, most importantly, his ability to explain complex health issues for our readers. He generates a lot of discussion with […]
Newsletters are notorious for re-using the same ad copy for years and years and years, and the Motley Fool is no different — when they get a marketing pitch that really works, they keep trotting it out again, and again, and again. I’ve mentioned this before, particularly with their “Next Berkshire Hathaway” pick that gets […]
I haven’t written about Yiannis Mostrous in a while, but his latest ad that teases a hot investment that he calls “The Next McDonald’s” definitely got my attention. It’s a big promise, after all: “Thousands of investors became millionaires and lived their dreams as 100 shares of McDonald’s split 12 times and turned into a […]
I guess now pretty much everyone has jumped aboard the Marijuana bandwagon — the Motley Fool is a bit later to the party, having just announced its Marijuana Masters investing service ($1,499, no refunds), helmed by David Kretzmann (a new name to me), so let’s see what it is that the typically much more mainstream […]
I need help understanding just what happened here. Last month Arena got approval from the FDA on their Obesity pill Biquig I bought in at ten thinking this was great news and the stock would increase in value. Well since then it has hovered between 9.50 and 11.50. Then last week Vivus got approval on […]
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
[ed note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who shares his non-investing thoughts with Stock Gumshoe readers a couple times a month. He selects his own topics, and his words and opinions are, of course, his own — you can see his previous commentaries […]
Yes, that’s not my headline — I borrowed it from the ad I was asked to look at, the “special presentation for fast-moving readers” from Agora Financial’s Microcap Millionaires. The other possible headline would have been, also from the ad, “This Tiny Company Could Be The Next Household-Name Mega-Brand.” So you see, that’s not much […]
The latest ad for The Casey Report caught my eye this week, partly because I thought they might be following in teasing eCobalt (ECSI)… but it turns out that’s not the case, this pitch from E.B. Tucker about the next cobalt bull market being driven by lithium-ion battery demand is all about two other cobalt […]
This is a quickie, dear friends, because, well, it’s a teaser pitch we’ve covered before. But I thought it worthwhile to take another quick look — and not just because I actually own the stock (though I’m sure I do pay more attention to stocks I own than to others). See, this one’s an opportunity […]
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
I watched the Grant’s Interest Rate Observer Conference this week via webcast, and it continues to be one of my favorite events — though I’d rather be there in person. These are some of my notes about the presentations I found most interesting… no “quick take” here, sorry, these are mostly notes and my responses. […]
I’ve gotten quite a few questions recently about “income” and “buy stocks cheap” letters that are clearly veiled hints about put option selling… so I thought I’d take a look at one of them. The ad in question today is from Karim Rahemtulla, who calls himself “The Frugal Millionaire” in this spiel and has been […]
The latest ad from Teeka Tiwari for the Palm Beach Letter is pushing the idea that you can somehow collect some incredible monthly income with an “off the books” retirement income source… here’s how it’s introduced: “Now, For the First Time Ever, a Former Wall Street Hedge Fund Manager Reveals How You Can Unlock the […]
This was originally published on June 3, 2013, and it continues to be one of the most-discussed topics we’ve covered during those years. The idea continues to be teased and promoted actively by Tom Dyson and his folks at Palm Beach Letter, sometimes using different names, so we’re re-posting it for those new readers who […]
What do I think? That’s what a lot of readers are asking during these volatile days… and there is, of course, no easy answer. My thoughts are all over the place, so today’s Friday File musings are going to run the gamut. Tesla (TSLA) is a good example of how the market is treating investors […]
Down 24.93% In the period from the 3rd of November up to including the 28th of March the stock went down 24.93% despite the 12% dividend growth and the 6% group revenue growth in 2017. Was the company really at its top performance in 2017 and is the price now thrown back to the real […]
I just realized that we blew through the 11-year anniversary of the launch of Stock Gumshoe just a few days ago… and forgot to have a party or light the fireworks or anything. Ooops. Guess I was distracted by this nutty stock market… so, “happy birthday to us!” And thank you, dearest Irregular, for making […]
This article originally ran on January 29, but must be circulating again in March because we’re getting questions from readers — so we re-share it with you today. In case you’re wondering, this “value” stock is now about 25% lower than it was when this article first hit our pages (and the ad first hit […]
Every year we resolve to do better, right? That’s the human condition — we are frail, weak, and conflicted… we are busy, irritable, and unfocused… and we want to do better. It’s no different for your friends here at Stock Gumshoe… so today, as we recover from the Ides of March, I offer up some […]
Qualcomm (QCOM) is now back to having a 4% yield… which was pretty hard to resist for me this week. The stock is in the headlines every day of late and is well off its highs, of course, following the high-profile pursuit by Broadcom (AVGO) that was called off this week, but not all the […]
#NeverAgain is a new American student-led organization that advocates for tighter regulations to prevent gun violence. It was started in February, 2018, by 20 students at Marjory Stoneman Douglas High School in Parkland, Florida, after 17 people were murdered by a shooter armed with an AR-15 style semi-automatic rifle, and now has tens of thousands […]
Jackpot Digital OTC JPOTF TSXV JP Interesting but very speculative but near bottom of price range. I do like the business model. Please do your own due diligence. The Company’s primary business model is the licensing of its ETG tables to casino operators in exchange for a monthly recurring revenue stream. LOL from website—watch it […]
The ides of February are dismal and dreary here in the wet and grey Pioneer Valley of Massachusetts, but we remain hopeful of the sunshine to come. What do I have to share with you, dear Irregulars, as we seek a little brightness to end the week? Well, I do have a few buys to […]
This thread was initiated in order to provide a dedicated page for the members interested in following developing events at Aptose Biosciences. All posts made here should be about it. Other comments about biotech should be posted to the latest general purpose biotech thread, which on the date this is being written is https://www.stockgumshoe.com/2018/02/biotech-discussion-continued/ , […]
We will no longer be publishing the commentary of Dr. KSS, who wrote about biotech stocks for the Irregulars for several years. Late last week, he decided to move on and resign from his work here. I imagine he will likely start his own publication of some sort in the future — all I know […]
2017 was a year of tremendous accomplishment for Clean Teq Holdings in every respect. We saw remarkable achievements in mine construction, in finance, and in market development, with landmark contracts in every business segment; We saw a complex business appear as if by magic, including business offices on four continents, and the launch of business […]
Travis- I went to look through previous commentary. What is your preferred method to buying, selling and holding your 3% physical precious metals? How do you mitigate the buying and selling fees? Do you actually store the stuff?
I’m full into “Annual Review” mode now, when I make sure to take a good hard look at each holding in my portfolio — some of my positions are very long-term oriented and don’t often come to mind except as thoughts of, “yes I’ll probably still hold this one pretty much forever” wash through my […]